During the US’s deadliest drug overdose crisis, opioid addiction is often treated more like the result of a patient’s poor decision-making, rather than what it is—a disease fueled by overprescription and compounded by social, economic, physical, and psychological factors.
Join 6/13 to learn about innovative programs being implemented here in Massachusetts, which ranks among the top ten states with the highest rates of opioid deaths in the US.
A panel of experts will discuss myths, realities, challenges and opportunities in treating opioid use disorders and how to prevent patients from falling through the cracks during a national crisis.
Peter Friedmann, MD, Chief Research Officer at Baystate Health and Associate Dean for Research at UMass Medical School
Liz Whynott, Director of HIV Health and Prevention at Tapestry Health in Florence, MA